{"componentChunkName":"component---src-templates-blog-post-js","path":"/Content_Hub_Opioids_special_populations/","webpackCompilationHash":"51d8f384bf036aeb3a93","result":{"data":{"site":{"siteMetadata":{"title":"GPPainHelp test","author":"Simon Victory"}},"markdownRemark":{"id":"8a5072b6-7c22-5ccb-8efc-1f77224f99b3","excerpt":"Opioids in special populations          back Opioids in special populations home Renal Impairment: impaired renal function avoid morphine…","html":"<p> Opioids in special populations         </p>\n<p><a href=\"Content_Hub.html\"><img src=\"images/backarrow.png\" alt=\"back\"></a></p>\n<h1>Opioids in special populations</h1>\n<p><a href=\"main_menu.html\"><img src=\"images/homebtn.png\" alt=\"home\"></a></p>\n<p>Renal Impairment: impaired renal function avoid morphine (can be used at lower doses, less frequently), caution with oxycodone or hydromorphone. Recommended opioids are fentanyl, buprenorphine or methadone</p>\n<p>Hepatic Impairment: caution with oxycodone.</p>\n<p>Elderly: morphine tends to be poorly tolerated in the elderly (probably as a reflection of impaired renal function). Buprenorphine patches (Norspan©) give a continuous infusion of low-dose opioid.</p>\n<p>Possible effects/characteristics:</p>\n<ul>\n<li>Confusion.</li>\n<li>Increased plasma free drug concentration related to reduced metabolism and distribution volume in the elderly.</li>\n<li>Reduced clearance of opioids related to reduced hepatic blood flow (up to 40-50% by age 75).</li>\n</ul>\n<p>Children: Contact the paediatric palliative care team at Royal Children’s Hospital <a href=\"tel:+61736461357\">07 3646 1357</a>.</p>\n<p>Opioid Dependence: Patients with a history of abuse of opioid analgesics should not be denied opioid analgesics for management of pain. Their care may need to involve a health professional with expertise in addiction therapy.</p>\n<p>Such patients may require higher than usual opioid doses to control pain (Therapeutic Guidelines: Palliative Care).</p>\n<p>See Therapeutic Guidelines: Palliative Care, ‘Managing Pain in Patients with Substance Use Disorders’, pp 226-7.</p>\n<p>Terminally Ill: Although patients may be unable to respond when close to death, there is no evidence to suggest sensation is reduced at this time. There should be no reduction in analgesia unless a judgment is made by a palliative care clinician that the patient is over-sedated or narcotised.</p>\n<p><img src=\"images/banner-long-footer-whitetext.png\" alt=\"cpcre\"> <img src=\"images/acrrm.png\" alt=\"cpcre\"></p>","frontmatter":{"title":null,"date":null}}},"pageContext":{"isCreatedByStatefulCreatePages":false,"slug":"/Content_Hub_Opioids_special_populations/","previous":{"fields":{"slug":"/Content_Hub_Route_delivery/"},"frontmatter":{"title":null}},"next":{"fields":{"slug":"/Content_Hub_Opioids_avoid/"},"frontmatter":{"title":null}}}}}